Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBT (2016 - 2025)

Historic EBT for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $4.6 million.

  • Mesa Laboratories' EBT rose 30730.72% to $4.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $14.1 million, marking a year-over-year increase of 10521.36%. This contributed to the annual value of $6.0 million for FY2025, which is 10216.25% up from last year.
  • Mesa Laboratories' EBT amounted to $4.6 million in Q4 2025, which was up 30730.72% from $2.0 million recorded in Q3 2025.
  • Mesa Laboratories' EBT's 5-year high stood at $7.0 million during Q2 2025, with a 5-year trough of -$275.3 million in Q1 2024.
  • For the 5-year period, Mesa Laboratories' EBT averaged around -$12.4 million, with its median value being $1.7 million (2021).
  • In the last 5 years, Mesa Laboratories' EBT surged by 198153.85% in 2021 and then crashed by 9929783.39% in 2024.
  • Quarter analysis of 5 years shows Mesa Laboratories' EBT stood at -$2.3 million in 2021, then skyrocketed by 181.85% to $1.9 million in 2022, then grew by 1.57% to $1.9 million in 2023, then plummeted by 213.93% to -$2.2 million in 2024, then soared by 307.31% to $4.6 million in 2025.
  • Its EBT was $4.6 million in Q4 2025, compared to $2.0 million in Q3 2025 and $7.0 million in Q2 2025.